Schedule 13D ownership disclosure

PROMIS NEUROSCIENCES INC

Common Shares, no par value per share · CUSIP: 74346M505

Event date: 2026-02-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ABG Management Ltd.Reported CIK 0001832106

    Shares: 572,677.00 · Class: 6.3%

  • Ally Bridge Group (NY) LLCReported CIK 0001822947

    Shares: 572,677.00 · Class: 6.3%

  • Ally Bridge MedAlpha Master Fund L.P.Reported CIK 0001831963

    Shares: 572,677.00 · Class: 6.3%

  • ABG V-SIV IX Limited

    Shares: 659,520.00 · Class: 7.1%

  • Ally Bridge Group Global Life Science Capital Partners V, L.P.

    Shares: 659,520.00 · Class: 7.1%

  • ABG Global Life Science Capital Partners V GP, L.P.

    Shares: 659,520.00 · Class: 7.1%

  • ABG Global Life Science Capital Partners V GP Limited

    Shares: 659,520.00 · Class: 7.1%

  • ABG V-SIV X Limited

    Shares: 412,200.00 · Class: 4.5%

  • Fan YuReported CIK 0001668029

    Shares: 1,644,397.00 · Class: 17.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-005412
Form type
SCHEDULE 13D/A
Filer
ABG Management Ltd.
CIK
CIK 1832106
Filed
Feb 05, 2026
Reporting period
Feb 03, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub